Clinical Trial Update: Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating preemptive immunointervention after allogeneic hematopoietic stem cell transplantation f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma | Phase 2 | Status: UNKNOWN